Skip to content
FrontierPicks

Watchlist

FBIZ · First Business Financial Services, Inc.

Last analysed ·

Against its published line

Nothing is through its line on this close.

How to read this

The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 4 September 2026; a dot LEFT of the mark has closed through its line.

Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.

How a pick resolves

Current thesis

Post-2026-07-30 re-rating in a micro-cap Wisconsin business bank: Q2 EPS $1.84 vs $1.54 consensus, NIM +22bp to 3.78%, record $19.8M pre-provision earnings, followed by target raises to $74 (KBW), $80 (DA Davidson) and $84 (Piper). Shares closed 2026-09-04 at $72.83, a 52-week high, with no company-dated catalyst until the ~2026-10-29 Q3 print, leaving a maturing leg carried by trend and the 2026-09-16 FOMC.

Kill line

A weekly close below $68 (gives back the post-2026-07-30 advance and the rising 50-day at $68.04); secondarily, a Q3 print (~2026-10-29) showing NIM under the 3.78% posted in Q2 or pre-provision earnings under the $19.8M record.

Pick status

Open commitment catalyst in 10dscored if the kill line above fires How this is scored →

Latest analysis and events for FBIZ —

As of 6 September 2026, the latest FrontierPicks analysis for First Business Financial Services, Inc. (FBIZ): Post-2026-07-30 re-rating in a micro-cap Wisconsin business bank: Q2 EPS $1.84 vs $1.54 consensus, NIM +22bp to 3.78%, record $19.8M pre-provision earnings, followed by target raises to $74 (KBW), $80 (DA Davidson) and $84 (Piper). Shares closed 2026-09-04 at $72.83, a 52-week high, with no company-dated catalyst until the ~2026-10-29 Q3 print, leaving a maturing leg carried by trend and the 2026-09-16 FOMC.

Kill line: A weekly close below $68 (gives back the post-2026-07-30 advance and the rising 50-day at $68.04); secondarily, a Q3 print (~2026-10-29) showing NIM under the 3.78% posted in Q2 or pre-provision earnings under the $19.8M record.

Next dated event on file: — catalyst in 10d.

Current Thesis

The leg on offer is an earnings-driven re-rating in a micro-cap commercial bank, not a thematic story. On 2026-07-30 First Business reported Q2 2026 net income available to common of $15.4M and $1.84 diluted EPS against a Zacks consensus of $1.54, on revenue of $46.71M (+13.8% YoY) versus a $45.5M consensus. Net interest margin widened 22bp to 3.78%, pre-tax pre-provision earnings hit a record $19.8M, the efficiency ratio came in at 59.31%, and management exited out-of-market SBA 7(a) lending. Three sell-side targets moved up behind the print. Shares closed 2026-09-04 at $72.83 — the 52-week high — with the 50-day at $68.04 and the 200-day at $59.12 (stockanalysis.com, 2026-09-05). The narrative is maturing: it has been public since the 2026-07-30 release, the target raises landed in the first days of August, and no company-dated datapoint exists before the Q3 print in late October, so the intervening tape is trend plus the 2026-09-16 FOMC.

Bullish and bearish views on First Business Financial Services, Inc.

The model's bull view on First Business Financial Services, Inc. (FBIZ), in brief: Q2 2026 beat was wide, 2026-07-30: $1.84 diluted EPS vs $1.54 consensus (+10.4% surprise); revenue $46.71M vs $45.5M (+2.66%). The bear view: The headline number is flattered. $1.84 contained $0.14 of net one-time benefit. Q3 has to clear the ex-item run rate without that help, and the market has already paid for the headline. The margin leg is rate-dependent. The 22bp expansion to 3.78% assumes deposit costs keep… Both cases follow in full.

Bull Case

  • Q2 2026 beat was wide, 2026-07-30: $1.84 diluted EPS vs $1.54 consensus (+10.4% surprise); revenue $46.71M vs $45.5M (+2.66%). The EPS figure includes a $0.14 net one-time benefit, which management flagged in the same release.
  • Margin, not just volume: NIM expanded 22bp to 3.78% in Q2, with loans growing 10% annualized and core deposits 12% annualized (Q2 2026 call, 2026-07-31). A margin-led quarter is harder to reverse than one built on a single fee item.
  • Record pre-provision earnings: $19.8M in Q2, up 15% for the first six months of 2026; efficiency ratio 59.31%.
  • Book value compounding: tangible book value per share rose 15.2% YoY as of the Q2 report — against a stated book value per share of $45.81 and price/book of 1.59 (stockanalysis.com, 2026-09-05).
  • Portfolio cleanup: the exit from out-of-market SBA 7(a) lending, announced with Q2 results on 2026-07-30, removes a gain-on-sale-dependent revenue line whose volatility argued for a lower multiple.
  • Capital return record: the quarterly dividend was raised 17% to $0.34 on 2026-01-29, described by the company as the 14th consecutive annual increase; the 2026-07-30 declaration paid 2026-08-26 to holders of record 2026-08-12.
  • Sell-side moved after the print: Keefe, Bruyette & Woods went to Outperform with a $74 target from $68 on 2026-08-03; DA Davidson carries $80; Piper Sandler reissued Overweight at $84, raised from $70.
  • Multiple still low in absolute terms: forward P/E of 10.99 (stockanalysis.com, 2026-09-05) for a bank compounding book value at a mid-teens rate.

Bear Case

  • The headline number is flattered. $1.84 contained $0.14 of net one-time benefit. Q3 has to clear the ex-item run rate without that help, and the market has already paid for the headline.
  • The margin leg is rate-dependent. The 22bp expansion to 3.78% assumes deposit costs keep repricing favourably. The 2026-09-16 FOMC carries a Summary of Economic Projections; a faster-cut dot plot pressures asset yields on a floating-rate commercial book before funding costs follow.
  • Sell-side upside is partly consumed. KBW's $74, set 2026-08-03, sits barely above the 2026-09-04 close of $72.83. Only the DA Davidson $80 and Piper $84 targets imply meaningful room, and neither has been refreshed since the print.
  • Size and liquidity. Market cap $609.46M on 8.37M shares outstanding (stockanalysis.com, 2026-09-05). The flow that carried a 25.3% three-month advance is small enough to reverse on one institutional reallocation.
  • Credit is the unmeasured leg. Nothing in the public record cited here quantifies non-performing assets or the provision trend for Q2 2026; a commercial-and-industrial and CRE-weighted balance sheet at 1.59x book is priced for that line staying quiet.
  • Seven weeks of nothing. From 2026-09-05 the only company action expected is the routine conference-call announcement in early October. A stock at its 52-week high with no fresh company datapoint depends on tape and the rate complex.

Setup & Price Structure

  • The 2026-09-04 close of $72.83 is the 52-week high, so there is no overhead supply from the prior twelve months. RSI(14) at 60.6 is not an extreme reading — momentum without the oscillator stretch that usually precedes a violent unwind.
  • Moving-average sequence is intact and rising: price $72.83, 50-day $68.04, 200-day $59.12 (2026-09-05). The $68 shelf is where the post-print advance would have to be given back.
  • The shares are up 25.3% over three months, with the bulk of the move dating from the 2026-07-30 release and the target raises that followed on 2026-08-03.
  • no squeeze mechanic here. Beta (5Y) 0.65, so this is a low-volatility tape where a 6%-plus weekly-close breakdown would itself be a signal rather than noise. Institutional filings show routine accumulation (Connor Clark & Lunn reported adding 12,193 shares, per a 2026-09-01 13F summary), a position size too small to read as crowding.
  • Retail-sentiment coverage of this name is thin; the attention that has arrived is sell-side, and it arrived within four days of the print. That is the pattern of a story already discovered by the people who follow small banks, and not yet by anyone else.

Catalyst Calendar (next 30 days)

  • 2026-09-16 — FOMC rate decision, 2:00pm ET, with Summary of Economic Projections and dot plot. The dominant near-term input to a 3.78% NIM.
  • ~2026-10-06 (est.) — Q3 2026 earnings conference-call announcement. The pattern: 2026-07-06 for the 2026-07-31 call, 2026-04-08 for the 2026-04-24 call.
  • ~2026-10-29 (est.) — Q3 2026 results, just outside the 30-day window. Q3 2025 results were released 2025-10-30 with the call on 2025-10-31. The quarterly dividend declaration has accompanied the earnings release each quarter this year (2026-01-29, 2026-04-23, 2026-07-30).

What Would Change Our Mind

The whole leg rests on one quarter and three target revisions, so the first break is structural: the post-print advance is defined by the rising 50-day at $68.04, and a weekly close below $68 would return price to the range it occupied before 2026-07-30 and remove the reason the sell-side moved. A close of that kind on the low-beta tape this name trades would not be an ordinary pullback.

The second break is fundamental and dated. If the Q3 print (~2026-10-29) shows NIM below the 3.78% posted in Q2, or pre-provision earnings below the $19.8M record, the margin-expansion argument stops compounding and the stock is left holding a 1.59x book multiple with no growth delta. A third condition is a rise in non-performing assets or provision expense disclosed in that same release, which would reprice the asset quality assumption embedded in the current multiple.

Finally, if the story goes mainstream — retail and generalist coverage arriving at a bank this size without a widening institutional bid behind it — that is the signature of a saturated leg rather than an accelerating one.

Correlation Notes

  • No current theme cluster carries this name; it is a single-name setup and the thesis does not lean on a group move. The nearest public proxies are the small-cap regional bank complex and the front end of the curve.
  • Beta (5Y) of 0.65 means the dominant factor is the rate path and credit cycle, not the AI/semis complex that drives most of the high-momentum tape. Correlation to index drawdowns driven by tech multiples should be low; correlation to a regional-bank credit scare should be high.
  • The 2026-09-16 FOMC is a shared factor across every asset-sensitive lender, so a break of $68 that coincides with a broad regional-bank selloff carries different information than an idiosyncratic one.

Notes

  • Micro-cap bank: $609.46M market cap on 8.37M shares outstanding (stockanalysis.com, 2026-09-05) — position-independent liquidity risk on any large reallocation.
  • Series A preferred stock is outstanding; preferred dividends are declared separately from the common (e.g. $17.50 per preferred share, 2025-11-06 declaration).
  • Quarterly EPS at this bank routinely carries one-time items — Q2 2026's $1.84 included a $0.14 net one-time benefit disclosed in the 2026-07-30 release.
  • The common dividend has been declared alongside the quarterly earnings release each quarter of 2026 (2026-01-29, 2026-04-23, 2026-07-30).

Related · shared themes

SEZL

Sezzle Inc.

Three higher closes into 2026-09-03 ($122.96, RSI 43.6) repaired the $117.18 post-gap shelf but left the 2026-08-17 close of $129.87 unreclaimed for thirteen sessions. The 2026-09-01 merchant announcement landed on a 5.5% down session and the bounce came from BofA's Affirm note, so the bid is still borrowed; the 09-15/09-17 conference window and the end-September OCC filing are the only dated company levers before Q3.

MEDIUM

ATEX

Anterix Inc.

The four-session slide stopped at the 2026-09-03 close of $87.10, $1.79 above the 2026-08-20 low close of $85.31 and 19.5% under the $108.2 52-week high. The conversion story has gone 135 days without an announced spectrum sale and 23 days without a company filing, leaving the 2026-09-21 buyback expiry as the only company-dated event inside 30 days.

LOW

DAVE

Dave Inc.

The two-session reclaim stalled at Piper Sandler's $390: after $340.64 (2026-09-01), $372.85 and $390.86, DAVE closed $380.69 on 2026-09-04, back under the line. No company-dated event exists before the ~2026-11-04 Q3 print, leaving a 2.31M-share short base at 24.65% of a 9.39M displayed float as the mechanism into the ~2026-09-10 short-interest read — a maturing story now priced by positioning rather than disclosure.

LOW

XMTR

Xometry, Inc.

Saturated post-print setup with no company-sourced numbers scheduled before roughly 2026-11-03: the 2026-08-04 beat-and-raise is fully absorbed by an 11-analyst panel averaging $110.3 whose $95 low mark sits above the $93.04 close, and Executive Chair Altschuler's proposed 10,000-share Form 144 was executed on 2026-09-01, making six insider disposals since 08-18 with no offsetting purchase. The 09-08 Goldman and 09-10 Citi firesides are the only company venues left this quarter.

LOW